MARTIN J TYLER 4
4 · DYNAVAX TECHNOLOGIES CORP · Filed Jan 7, 2011
Insider Transaction Report
Form 4
MARTIN J TYLER
VP Clinical Development & CMO
Transactions
- Award
Option (Right to Buy)
2011-01-06+550,000→ 550,000 totalExercise: $3.14Exp: 2021-01-05→ Common Stock (550,000 underlying)
Footnotes (2)
- [F1]This option grant vests at the rate of 1/3rd of the shares on the first anniversary of the vesting commencement date, with 1/36th of the total number of shares vesting each month thereafter, subject to continued service with the Company through each applicable vesting date.
- [F2]Not applicable.